Results 251 to 260 of about 3,763,455 (305)

Vaccines for papillomavirus infection

Virus Research, 2002
Vaccines to prevent PV infection, utilising PV L1 virus like particles (VLPs) to induce neutralising antibody, are in clinical trial and show all the characteristics likely to be associated with success. Results warrant global planning for the deployment of VLP vaccines within a decade, as part of a program to prevent cervical cancer. Vaccines designed
openaire   +5 more sources

THERAPEUTIC APPROACHES TO PAPILLOMAVIRUS INFECTIONS

Dermatologic Clinics, 1997
Human papillomaviruses (HPVs) cause benign tumors (i.e., warts) and are occasionally responsible for malignant tumors such as squamous-cell carcinomas. Therapy for most warts is commonly via surgical or cytodestructive methods. Presently, only one antiviral/immunomodulatory drug is available for wart therapy; this agent, interferon alpha (IFN alpha ...
G E, Baker, S K, Tyring
openaire   +2 more sources

Epidemiology of Human Papillomavirus Infections

Hospital Practice, 1997
(1997). Epidemiology of Human Papillomavirus Infections. Hospital Practice: Vol. 32, No. 11, pp. 39-41.
E J, Mayeaux, S D, Spigener
openaire   +2 more sources

Epidemiology of human papillomavirus infections.

Dermatologic Clinics, 1991
Human papillomavirus infection represents the most common mucocutaneous viral infection, and 3% to 5% of all patients have clinically evident warts. Human papillomavirus infections of the genital tract are one of the most common sexually transmitted viral infections in the United States. Data from STD clinics and private physicians' offices reveal that
K. Beutner, T. Becker, K. M. Stone
semanticscholar   +3 more sources

Interferons in human papillomavirus infections

Antiviral Research, 1994
Human papillomavirus (HPV) infections usually present as benign warts (e.g., condyloma acuminatum, CA) but can also be responsible for dysplasia and carcinoma. Therapeutic options include chemotherapeutic agents, cryotherapy and surgery, but all these treatments are anti-tumor, not anti-viral.
R, Cirelli, S K, Tyring
openaire   +2 more sources

Epidemiology of Human Papillomavirus Infection

Scandinavian Journal of Urology and Nephrology, 2000
Anogenital human papillomavirus (HPV) infection is a sexually transmitted disease (STD) that typically follows a self-limiting transient course for both sexes. The HPV incidences and prevalences vary greatly, because they reflect the sexual activity of the individuals studied and of the population they are in contact with.
J, Dillner, C J, Meijer, G, von Krogh, S, Horenblas   +3 more
openaire   +2 more sources

Genital human papillomavirus infections

Current Opinion in Urology, 2002
Human papillomavirus infections of the genitals are very widespread in the sexually active population throughout the world. Not only cosmetically unattractive skin warts but also genital squamous epithelial carcinomas of both sexes may be caused by human papillomavirus infections.
openaire   +2 more sources

Genital Human Papillomavirus Infections

Clinics in Laboratory Medicine, 1989
Genital human papillomavirus (HPV) infection is an increasingly common sexually transmitted disease that has been associated with carcinoma of the cervix. Genital warts are easily diagnosed by clinical criteria; however, the more prevalent subclinical infections generally require laboratory diagnosis.
J M, Douglas, B A, Werness
openaire   +2 more sources

Human Papillomavirus: The Burden of Infection

Obstetrical & Gynecological Survey, 2006
Vaccines for preventing human papillomavirus (HPV) infection are far along in clinical development and testing, and hold great promise for reducing HPV infections and HPV-associated disease. HPV is the most common sexually transmitted infection in the United States, affecting an estimated 75% of the U.S. population. HPV infection is highly prevalent in
Dorothy, Wiley, Emmanuel, Masongsong
openaire   +2 more sources

Classification of Human Papillomavirus Infection

JAMA: The Journal of the American Medical Association, 1993
To the Editor. —Infection with oncogenic strains of human papillomavirus (HPV) constitutes a major risk factor for development of precancerous neoplastic lesions and/or cancer of the cervix.1The inability to culture HPV and the lack of reliable serologic tests have hindered characterization of the life cycle and the natural course of HPV infection.2 ...
E A, Morrison, R D, Burk
openaire   +2 more sources